These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2933951)

  • 1. Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists.
    Kiowski W; Bühler FR; Fadayomi MO; Erne P; Müller FB; Hulthén UL; Bolli P
    Am J Cardiol; 1985 Dec; 56(16):81H-85H. PubMed ID: 2933951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.
    Brouwer RM; Bolli P; Erné P; Conen D; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S88-91. PubMed ID: 2580183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the hypotensive effects of calcium antagonists.
    Erne P; Bolli P; Bertel O; Hulthen UL; Kiowski W; Muller FB; Buhler F
    Hypertension; 1983; 5(4 Pt 2):II97-102. PubMed ID: 6345378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Place of calcium antagonists in antihypertensive therapy: introduction and round-table discussion.
    Bühler FR; Distler A; Laragh JH; Tourkantonis D; Valdes G; Weber MA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-32. PubMed ID: 6085379
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium antagonists and the second drug for hypertensive therapy.
    Müller FB; Bolli P; Linder L; Kiowski W; Erne P; Bühler FR
    Am J Med; 1986 Dec; 81(6A):25-9. PubMed ID: 2879444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonism--a new concept for treating essential hypertension.
    Müller FB; Bolli P; Erne P; Kiowski W; Bühler FR
    Am J Cardiol; 1986 Feb; 57(7):50D-53D. PubMed ID: 3006467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age related antihypertensive effect of nitrendipine, a new calcium entry blocking agent.
    Ferrara LA; Fasano ML; Soro S
    Eur J Clin Pharmacol; 1985; 28(4):473-4. PubMed ID: 3161743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of calcium antagonists with other antihypertensive agents.
    Doyle AE
    Am J Cardiol; 1986 Feb; 57(7):90D-92D. PubMed ID: 2869675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
    Arigoni C; Rusca A; Pusterla CE; Beretta-Piccoli C
    Schweiz Med Wochenschr; 1987 Jul; 117(30):1152-7. PubMed ID: 3313686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists as first-choice therapy for low-renin essential hypertension.
    Bühler FR
    Kidney Int; 1989 Aug; 36(2):295-305. PubMed ID: 2674520
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
    Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
    Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The specificity of the hypotensive effect of calcium antagonists in hypertension].
    Ivleva AIa; Kobalava ZhD; Antiia ID; Krasnobaeva GM; Iartsev VE; Lepakhin VK; Moiseev VS
    Ter Arkh; 1991; 63(9):97-100. PubMed ID: 1759235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrendipine in the treatment of mild to moderate hypertension.
    Moser M; Lunn J; Nash DT; Burris JF; Winer N; Simon G; Vlachakis ND
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1085-9. PubMed ID: 6085372
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
    M'Buyamba-Kabangu JR; Lepira B; Fagard R; Lijnen P; Ditu M; Tshiani KA; Amery A
    Eur J Clin Pharmacol; 1986; 29(5):523-7. PubMed ID: 2869952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.